范可尼贫血与乳腺癌易感性。 - Suppr

Suppr

超能文献

Fanconi anemia and breast cancer susceptibility.

作者信息

Patel Ketan J

出版信息

Nat Genet. 2007 Feb;39(2):142-3. doi: 10.1038/ng0207-142.

DOI:10.1038/ng0207-142

PMID:17262024

Abstract

摘要

相似文献

Fanconi anemia and breast cancer susceptibility.

Nat Genet. 2007 Feb;39(2):142-3. doi: 10.1038/ng0207-142.

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Nat Genet. 2007 Feb;39(2):159-61. doi: 10.1038/ng1942. Epub 2006 Dec 31.

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.

Nat Genet. 2007 Feb;39(2):162-4. doi: 10.1038/ng1947. Epub 2006 Dec 31.

Biomedicine. D-Day for BRCA2.

Science. 2002 Jul 26;297(5581):534. doi: 10.1126/science.1074482. Epub 2002 Jun 13.

Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.

Fetal Pediatr Pathol. 2017 Feb;36(1):49-61. doi: 10.1080/15513815.2016.1225873. Epub 2016 Oct 3.

Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.

Carcinogenesis. 2009 Nov;30(11):1898-902. doi: 10.1093/carcin/bgp218. Epub 2009 Sep 8.

New complexities for BRCA1 and BRCA2.

Curr Biol. 2001 Aug 21;11(16):R668-76. doi: 10.1016/s0960-9822(01)00389-x.

Susceptibility pathways in Fanconi's anemia and breast cancer.

N Engl J Med. 2010 May 20;362(20):1909-19. doi: 10.1056/NEJMra0809889.

Fanconi anemia: Fanconi anemia, breast and embryonal cancer risk revisited.

Eur J Hum Genet. 2007 Jul;15(7):715-7. doi: 10.1038/sj.ejhg.5201860. Epub 2007 May 16.

A growing network of cancer-susceptibility genes.

N Engl J Med. 2003 May 8;348(19):1917-9. doi: 10.1056/NEJMcibr023150.

引用本文的文献

DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy.

J Oncol. 2019 Jun 19;2019:4325105. doi: 10.1155/2019/4325105. eCollection 2019.

The biological effects and clinical implications of BRCA mutations: where do we go from here?

Eur J Hum Genet. 2016 Sep;24 Suppl 1(Suppl 1):S3-9. doi: 10.1038/ejhg.2016.93.

Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673.

Pediatr Blood Cancer. 2015 Jan;62(1):91-8. doi: 10.1002/pbc.25201. Epub 2014 Sep 27.

Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

Cancer Discov. 2013 Apr;3(4):399-405. doi: 10.1158/2159-8290.CD-12-0421. Epub 2012 Dec 26.

RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.

Carcinogenesis. 2010 Dec;31(12):2031-8. doi: 10.1093/carcin/bgq210. Epub 2010 Oct 15.

Fanconi anemia and breast cancer susceptibility meet again.

Nat Genet. 2010 May;42(5):368-9. doi: 10.1038/ng0510-368.

Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.

Am J Pathol. 2010 Jun;176(6):2935-47. doi: 10.2353/ajpath.2010.090779. Epub 2010 Apr 2.

Cancer incidence in relatives of British Fanconi Anaemia patients.

BMC Cancer. 2008 Sep 11;8:257. doi: 10.1186/1471-2407-8-257.

Hereditary breast cancer: new genetic developments, new therapeutic avenues.

Hum Genet. 2008 Aug;124(1):31-42. doi: 10.1007/s00439-008-0529-1. Epub 2008 Jun 25.

Biomarkers and mechanisms of FANCD2 function.

J Biomed Biotechnol. 2008;2008:821529. doi: 10.1155/2008/821529.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Fanconi anemia and breast cancer susceptibility.

Nat Genet. 2007 Feb;39(2):142-3. doi: 10.1038/ng0207-142.

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Nat Genet. 2007 Feb;39(2):159-61. doi: 10.1038/ng1942. Epub 2006 Dec 31.

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.

Nat Genet. 2007 Feb;39(2):162-4. doi: 10.1038/ng1947. Epub 2006 Dec 31.

Biomedicine. D-Day for BRCA2.

Science. 2002 Jul 26;297(5581):534. doi: 10.1126/science.1074482. Epub 2002 Jun 13.

Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.

Fetal Pediatr Pathol. 2017 Feb;36(1):49-61. doi: 10.1080/15513815.2016.1225873. Epub 2016 Oct 3.

Carcinogenesis. 2009 Nov;30(11):1898-902. doi: 10.1093/carcin/bgp218. Epub 2009 Sep 8.

New complexities for BRCA1 and BRCA2.

Curr Biol. 2001 Aug 21;11(16):R668-76. doi: 10.1016/s0960-9822(01)00389-x.

Susceptibility pathways in Fanconi's anemia and breast cancer.

N Engl J Med. 2010 May 20;362(20):1909-19. doi: 10.1056/NEJMra0809889.

Fanconi anemia: Fanconi anemia, breast and embryonal cancer risk revisited.

Eur J Hum Genet. 2007 Jul;15(7):715-7. doi: 10.1038/sj.ejhg.5201860. Epub 2007 May 16.

A growing network of cancer-susceptibility genes.

N Engl J Med. 2003 May 8;348(19):1917-9. doi: 10.1056/NEJMcibr023150.

引用本文的文献

DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy.

J Oncol. 2019 Jun 19;2019:4325105. doi: 10.1155/2019/4325105. eCollection 2019.

The biological effects and clinical implications of BRCA mutations: where do we go from here?

Eur J Hum Genet. 2016 Sep;24 Suppl 1(Suppl 1):S3-9. doi: 10.1038/ejhg.2016.93.

Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673.

Pediatr Blood Cancer. 2015 Jan;62(1):91-8. doi: 10.1002/pbc.25201. Epub 2014 Sep 27.

Biallelic deleterious BRCA1 mutations in a woman with early-onset ovarian cancer.

Cancer Discov. 2013 Apr;3(4):399-405. doi: 10.1158/2159-8290.CD-12-0421. Epub 2012 Dec 26.

RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.

Carcinogenesis. 2010 Dec;31(12):2031-8. doi: 10.1093/carcin/bgq210. Epub 2010 Oct 15.

Fanconi anemia and breast cancer susceptibility meet again.

Nat Genet. 2010 May;42(5):368-9. doi: 10.1038/ng0510-368.

Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.

Am J Pathol. 2010 Jun;176(6):2935-47. doi: 10.2353/ajpath.2010.090779. Epub 2010 Apr 2.

Cancer incidence in relatives of British Fanconi Anaemia patients.

BMC Cancer. 2008 Sep 11;8:257. doi: 10.1186/1471-2407-8-257.

Hereditary breast cancer: new genetic developments, new therapeutic avenues.

Hum Genet. 2008 Aug;124(1):31-42. doi: 10.1007/s00439-008-0529-1. Epub 2008 Jun 25.

Biomarkers and mechanisms of FANCD2 function.

J Biomed Biotechnol. 2008;2008:821529. doi: 10.1155/2008/821529.